Edition:
United Kingdom

Anixa Biosciences Inc (ANIX.OQ)

ANIX.OQ on NASDAQ Stock Exchange Capital Market

3.97USD
14 Dec 2018
Change (% chg)

$-0.03 (-0.75%)
Prev Close
$4.00
Open
$3.96
Day's High
$3.98
Day's Low
$3.89
Volume
1,653
Avg. Vol
27,490
52-wk High
$6.86
52-wk Low
$2.28

Latest Key Developments (Source: Significant Developments)

Itus Corporation Terminates At-The-Market Offering
Tuesday, 12 Dec 2017 

Dec 12 (Reuters) - Itus Corp ::ITUS CORPORATION TERMINATES AT-THE-MARKET OFFERING.‍TERMINATED ITS AT-THE-MARKET EQUITY PROGRAM WITH B. RILEY FBR INC​.  Full Article

Itus enters into 2-year collaboration agreement
Wednesday, 22 Nov 2017 

Nov 22 (Reuters) - Itus Corp ::Itus Corp - ‍on Nov 17, co, through unit entered into a 2 -year collaboration agreement with H. Lee Moffitt Cancer Center And Research Institute​.Itus - ‍ deal to advance toward human clinical testing car-t technology licensed by unit from Wistar Institute aimed initially at treating ovarian cancer​.Itus Corp says unit of co to pay Moffitt $1.16 million over two years for its efforts in collaboration - SEC filing.Itus Corp - unit to work with researchers at Moffitt to complete studies necessary to submit an IND application for technology with U.S. FDA​.Itus Corp - ‍first payment from unit to Moffitt to be paid upon execution of agreement, and subsequent installments to be paid periodically thereafter​.  Full Article

ITUS Corp licenses CAR-T technology from Wistar Institute
Tuesday, 14 Nov 2017 

Nov 14 (Reuters) - ITUS Corp :ITUS Corporation licenses CAR-T technology from the Wistar Institute.Itus Corp - ‍executed exclusive worldwide license agreement with Wistar Institute for a Chimeric Antigen Receptor T-Cell (CAR-T) technology.ITUS Corp - has formed a subsidiary, Certainty Therapeutics Inc, to develop and commercialize innovative CAR-T technology​.  Full Article

ITUS Corp files for stock shelf offering of up to $24 mln
Monday, 16 Oct 2017 

Oct 16 (Reuters) - ITUS Corp :ITUS Corp - files for stock shelf offering of up to $24 million - SEC filing‍​.  Full Article